Prader-Willi syndrome is a rare genetic disease that causes poor feeding in infancy but later triggers insatiable hunger.

DCCR was approved by the U.S. Food and Drug Administration (FDA) under the brand name VYKAT™ XR on March 26, 2025. Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental disorder caused by ...

In a comprehensive Genomic Press Invited Expert Review, researchers from the University of Haifa have synthesized cutting-edge findings on Prader-Willi syndrome (PWS), revealing how this complex ...

Batesburg residents are coming together for a cause that touches lives in a very personal way. On May 22nd, the Babcock Center will host the annual Prader-Willi Walk ...

HAIFA, Israel, 20 May 2025 – In a comprehensive Genomic Press Invited Expert Review, researchers from the University of Haifa have synthesized cutting-edge findings on Prader-Willi syndrome (PWS ...

May 15 marks National Prader-Willi Syndrome Awareness Day. For one Virginia father, the date is more than just a spot on the calendar -- it's a call to action.

In a comprehensive Genomic Press Invited Expert Review, researchers from the University of Haifa have synthesized ...

VYKAT XR was approved by the U.S. Food and Drug Administration (FDA) on March 26, 2025, and is now commercially available to ...

VYKAT XR was approved by the U.S. Food and Drug Administration (FDA) on March 26, 2025, and is now commercially available to ...